PMID: 9175570Mar 1, 1997Paper

Impact of the renin-angiotensin-aldosterone system on blood pressure response to intravenous enalaprilat in patients with hypertensive crises

Journal of Human Hypertension
M M HirschlA N Laggner

Abstract

The purpose of the study was to evalute the impact of the renin-angiotensin-aldosterone (RAA) system on blood pressure (BP) response in patients with hypertensive emergencies and urgencies treated with intravenous enalaprilat. Thirty-five patients with a systolic BP (SBP) >210 mm Hg and/or diastolic BP (DBP) >110 mm Hg received 5 mg enalaprilat intravenously. The extent of systolic and DBP reduction was correlated with pretreatment concentrations of angiotensin II (ANGII) (SBP: r = -0.47; P = 0.006; DBP: r = -0.55; P = 0.001) and plasma renin activity (PRA) (SBP: r = -0.49; P = 0.003; DBP: r = 0.48; P = 0.007). Non-responders to enalaprilat exhibited significant lower pretreatment levels of PRA, angiotensin-converting enzyme (ACE) and ANG II compared to responders (PRA: 5.5 +/- 3.7 vs 1.1 +/- 2.2 ng/ml/h, P < 0.001; ACE: 12.8 +/- 3.5 vs 8.2 +/- 4.8 U/l, P = 0.003; ANG 11:8.7 +/- 6.2 vs 5.0 +/- 3.8 pg/ml, P = 0.04). In patients with severe hypotension following application of enalaprilat ANG II concentrations were significantly higher compared to patients with mean arterial BP reduction <25% (12.3 +/- 6.7 vs 5.6 +/- 4.0 pg/ml,P = 0.013). These data indicate that PRA and ANG II are the major determinants for BP response to enalap...Continue Reading

Citations

Dec 8, 2006·Seminars in Dialysis·Andrew R Haas, Paul E Marik
Sep 17, 2003·Critical Care : the Official Journal of the Critical Care Forum·Joseph Varon, Paul E Marik
Jun 15, 2007·Chest·Paul E Marik, Joseph Varon
Jul 14, 2000·Chest·J Varon, P E Marik
Sep 28, 2015·The Journal of Emergency Medicine·Adnan KayaAhmet Murat
May 9, 2006·Critical Care Clinics·Denise H Rhoney, Xi Liu-DeRyke
Oct 11, 2003·Journal of Clinical Pharmacology·L Michael PrisantWeizhong He
Dec 4, 2003·British Journal of Clinical Pharmacology·D PattersonT MacDonald
Jul 29, 2009·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Denise Rhoney, W Frank Peacock
Feb 27, 2019·Critical Care Nursing Quarterly·J Tyler HallerKeaton S Smetana
Jan 31, 2009·Postgraduate Medicine·Joseph Varon
Oct 12, 2011·Current Opinion in Critical Care·Paul E Marik, Racquel Rivera
Jul 18, 2002·Holistic Nursing Practice·D J Rosenow, E Russell
May 28, 2010·Blood Pressure·Dimitris P PapadopoulosVasilios Papademetriou
Jul 14, 2001·Critical Care Clinics·W J Elliott

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.